Most studies have shown the importance of using the Ki-67 marker in squamous cell tumors of the head and neck for prognostic purposes, detection of premalignant lesions, or implications for therapeutic treatments [18,19]. The gene discussed is MKI67; the disease is squamous cell neoplasm.